Robert J. O'Shea, 10% Owner at PDL BIOPHARMA, INC. (PDLI), bought 631,600 shares at $2.70 ($1.7M) on 2020-12-28, disclosed to the SEC on 2020-12-29.
Open-market purchase of $1.7M PDLI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.65 | 128,000 | $339K | 20.0% |
| 2 | $2.70 | 235,000 | $635K | 37.4% |
| 3 | $2.69 | 268,600 | $723K | 42.6% |
| Total | $2.69 avg | 631,600 | $1.7M | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateKeenova Therapeutics plc | BUY | 2025-12-10 | $23.2M | — | Filing → |
| PrivateCopper Property CTL Pass Through Trust | BUY |
| 2025-10-23 |
| $10.7M |
| — |
| Filing → |
| PrivateCopper Property CTL Pass Through Trust | BUY | 2025-10-21 | $3.8M | — | Filing → |
| PrivateCopper Property CTL Pass Through Trust | BUY | 2025-08-06 | $889K | — | Filing → |
| GPOR | SELL | 2024-11-25 | $166.1M | — | Filing → |